- Home
- SEED vs SILO Comparison
SEED vs SILO Comparison
Compare SEED & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEED
- SILO
- Stock Information
- Founded
- SEED 1997
- SILO 2010
- Country
- SEED China
- SILO United States
- Employees
- SEED N/A
- SILO N/A
- Industry
- SEED Farming/Seeds/Milling
- SILO Apparel
- Sector
- SEED Consumer Staples
- SILO Consumer Discretionary
- Exchange
- SEED Nasdaq
- SILO Nasdaq
- Market Cap
- SEED 8.6M
- SILO 8.0M
- IPO Year
- SEED N/A
- SILO N/A
- Fundamental
- Price
- SEED $1.80
- SILO $0.60
- Analyst Decision
- SEED
- SILO
- Analyst Count
- SEED 0
- SILO 0
- Target Price
- SEED N/A
- SILO N/A
- AVG Volume (30 Days)
- SEED 3.4M
- SILO 891.9K
- Earning Date
- SEED 06-26-2025
- SILO 11-11-2025
- Dividend Yield
- SEED N/A
- SILO N/A
- EPS Growth
- SEED N/A
- SILO N/A
- EPS
- SEED N/A
- SILO N/A
- Revenue
- SEED $12,910,081.00
- SILO $72,102.00
- Revenue This Year
- SEED N/A
- SILO $1.86
- Revenue Next Year
- SEED N/A
- SILO N/A
- P/E Ratio
- SEED N/A
- SILO N/A
- Revenue Growth
- SEED N/A
- SILO N/A
- 52 Week Low
- SEED $0.74
- SILO $0.40
- 52 Week High
- SEED $2.98
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- SEED 62.23
- SILO 45.96
- Support Level
- SEED $1.85
- SILO $0.53
- Resistance Level
- SEED $2.22
- SILO $0.58
- Average True Range (ATR)
- SEED 0.24
- SILO 0.06
- MACD
- SEED 0.01
- SILO -0.01
- Stochastic Oscillator
- SEED 44.35
- SILO 63.89
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.